Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Innovations in Pharmacy|May 22, 2025
Appropriate Use of Inpatient Erythropoiesis Stimulating AgentsChenghao Cui, Timothy Nguyen, Mohammad A RattuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 5, 2026
Safety of cyclophosphamide infusion time modification from 60 to 30 minutes in selected chemotherapy regimens for lymphoma and multiple myelomaSarah Dean, Carli Beall, Mohammad A RattuExpert Opinion on Biological Therapy|February 9, 2025
An evaluation of linvoseltamab for treatment of relapsed/refractory multiple myelomaZachary M Avigan, Mohammad A Rattu, Joshua RichterJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 27, 2014
A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinibChung-Shien Lee, Mohammad A Rattu, Sara S KimP & T : a Peer-Reviewed Journal for Formulary Management|January 7, 2014
Glucarpidase (voraxaze), a carboxypeptidase enzyme for methotrexate toxicityMohammad A Rattu, Neal Shah, Jessica M Lee, et al.Future Oncology (London, England)|July 8, 2026
Belantamab mafodotin, a BCMA-directed antibody-drug conjugate for multiple myelomaMarina Samuel, Marcus S Flores, Jacob A Lowy, et al.Expert Review of Hematology|February 18, 2026
Linvoseltamab, a BCMA-directed CD3 T-cell engager for multiple myeloma: a patient-centric option via a response-adapted dosing regimen?Jacob A Lowy, Michael F Rogers, Zachary M Avigan, et al.Journal of the Advanced Practitioner in Oncology|July 2, 2025
Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab: Highlights From Pharmacists' PerspectivesTyler Sandahl, Mohammad A Rattu, Grace Jiang, et al.Pageof 1